Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells
Authors:
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 345 (2) , 720-725
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Regulation of Prostaglandin Metabolism by Calcitriol Attenuates Growth Stimulation in Prostate Cancer CellsCancer Research, 2005
- Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and InsigsJournal of Biological Chemistry, 2004
- Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cellsJournal of Cellular Biochemistry, 2004
- Keratinocyte G2/M Growth Arrest by 1,25-Dihydroxyvitamin D3 Is Caused by Cdc2 Phosphorylation Through Wee1 and Myt1 RegulationJournal of Investigative Dermatology, 2004
- Hypovitaminosis D is associated with insulin resistance and β cell dysfunctionThe American Journal of Clinical Nutrition, 2004
- 25‐Hydroxyvitamin D 3 is an active hormone in human primary prostatic stromal cellsThe FASEB Journal, 2003
- Inhibition of fatty acid synthase expression by 1α,25-dihydroxyvitamin D3 in prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Vitamin D: More Than a “Bone-a-Fide” HormoneMolecular Endocrinology, 2003
- cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid MetabolismJournal of Biological Chemistry, 1998
- Sunlight, cholesterol and coronary heart diseaseQJM: An International Journal of Medicine, 1996